A detailed history of Capital Investment Counsel, LLC transactions in Amgen Inc stock. As of the latest transaction made, Capital Investment Counsel, LLC holds 18,187 shares of AMGN stock, worth $5.09 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
18,187
Previous 17,570 3.51%
Holding current value
$5.09 Million
Previous $5.49 Billion 6.75%
% of portfolio
1.01%
Previous 1.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $190,887 - $208,163
617 Added 3.51%
18,187 $5.86 Billion
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $290,338 - $352,837
1,105 Added 6.71%
17,570 $5.49 Billion
Q1 2024

Aug 14, 2024

BUY
$268.87 - $324.56 $1.74 Million - $2.1 Million
6,485 Added 64.98%
16,465 $4.68 Billion
Q4 2023

Aug 14, 2024

BUY
$255.7 - $288.46 $2.55 Million - $2.88 Million
9,980 New
9,980 $2.87 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capital Investment Counsel, LLC Portfolio

Follow Capital Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Counsel, LLC with notifications on news.